Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures

Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846 · see citing works

Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis

Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J. A., Downs, R. W., Dequeker, J., Favus, M. J., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,276 · see citing works

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

Khosla, S., Burr, D., Cauley, J., Dempster, D. W., Ebeling, P. R., Felsenberg, D., Gagel, R. F., Gilsanz, V., Guise, T., Koka, S., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0707onj · Cited by 1,650 · see citing works

Severely Suppressed Bone Turnover: A Potential Complication of Alendronate Therapy

Odvina, C. V., Zerwekh, J. E., Rao, D. S., Maalouf, N. M., Gottschalk, F., & Pak, C. Y. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0952 · Cited by 1,429 · see citing works

Effects of Continuing or Stopping Alendronate After 5 Years of Treatment: The Fracture Intervention Trial Long-term Extension (FLEX): A Randomized Trial

Black, D. M., Schwartz, A. V., Ensrud, K. E., Cauley, J. A., Levis, S., Quandt, S. A., Satterfield, S., Wallace, R. B., Bauer, D. C., Palermo, L., et al. (2006) · JAMA · doi:10.1001/jama.296.24.2927 · Cited by 1,407 · see citing works

Bone histomorphometry : techniques and interpretation

Recker, R. R. (1983) · CRC Press eBooks · Cited by 1,160 · see citing works

Excess mortality following hip fracture: a systematic epidemiological review

Abrahamsen, B., van Staa, T., Ariely, R., Olson, M., & Cooper, C. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0920-3 · Cited by 1,079 · see citing works

An estimate of the worldwide prevalence, mortality and disability associated with hip fracture

Johnell, O., & Kanis, J. A. (2004) · Osteoporosis International · doi:10.1007/s00198-004-1627-0 · Cited by 962 · see citing works

Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus

Saito, M., & Marumo, K. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1066-z · Cited by 914 · see citing works

Novel Insights into Actions of Bisphosphonates on Bone: Differences in Interactions with Hydroxyapatite

Nancollas, G. H., Tang, R., Phipps, R. J., Henneman, Z., Gulde, S., Wu, W., Mangood, A., Russell, R. G. G., & Ebetino, F. H. (2006) · Bone · doi:10.1016/j.bone.2005.05.003 · Cited by 862 · see citing works

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid.

Wood, J., Bonjean, K., Ruetz, S., Bellahcène, A., Devy, L., Foidart, J. M., Castronovo, V., & Green, J. R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035295 · Cited by 854 · see citing works

Age-related changes in the collagen network and toughness of bone

Wang, X., Shen, X., Li, X., & Agrawal, C. M. (2002) · Bone · doi:10.1016/s8756-3282(01)00697-4 · Cited by 769 · see citing works

Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib

Mashiba, T., Hirano, T., Turner, C. H., Forwood, M. R., Johnston, C. C., & Burr, D. B. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.613 · Cited by 687 · see citing works

Bone mineralization density distribution in health and disease

Roschger, P., Paschalis, E. P., Fratzl, P., & Klaushofer, K. (2007) · Bone · doi:10.1016/j.bone.2007.10.021 · Cited by 650 · see citing works

Epidemiology of fractures in 15 000 adults: The influence of age and gender

Singer, B. R., McLauchlan, G. J., Robinson, C. M., & Christie, J. H. (1998) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.80b2.7762 · Cited by 595 · see citing works

Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women

Boivin, G., Chavassieux, P., Santora, A. C., Yates, J., & Meunier, P. J. (2000) · Bone · doi:10.1016/s8756-3282(00)00376-8 · Cited by 573 · see citing works

Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats.

Fournier, P. G. J., Boissier, S., Filleur, S., Guglielmi, J., Cabon, F., Colombel, M. C., & Clézardin, P. (2002) · PubMed · Cited by 562 · see citing works

Aging and matrix microdamage accumulation in human compact bone

Schaffler, M. B., Choi, K., & Milgrom, C. (1995) · Bone · doi:10.1016/8756-3282(95)00370-3 · Cited by 543 · see citing works

Influence of nonenzymatic glycation on biomechanical properties of cortical bone

Vashishth, D., Gibson, G. J., Khoury, J. I., Schaffler, M. B., Kimura, J., & Fyhrie, D. P. (2001) · Bone · doi:10.1016/s8756-3282(00)00434-8 · Cited by 525 · see citing works

Low-Energy Femoral Shaft Fractures Associated With Alendronate Use

Neviaser, A. S., Lane, J. M., Lenart, B. A., Edobor‐Osula, F., & Lorich, D. G. (2008) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0b013e318172841c · Cited by 525 · see citing works

Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.

Chavassieux, P., ARLOT, M. E., Reda, C. V., Wei, L., Yates, A. J. P., & Meunier, P. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119668 · Cited by 523 · see citing works

Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures

Aspenberg, P., Genant, H. K., Johansson, T., Nino, A. J., See, K., Krohn, K., García-Hernández, P. A., Recknor, C. P., Einhorn, T. A., Dalsky, G. P., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090731 · Cited by 513 · see citing works

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

Black, D. M., Kelly, M. P., Genant, H. K., Palermo, L., Eastell, R., Bucci-Rechtweg, C. M., Cauley, J. A., Leung, P., Boonen, S., Santora, A. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001086 · Cited by 511 · see citing works

Subtrochanteric insufficiency fractures in patients on alendronate therapy

Goh, S. K., Yang, K.-Y., Koh, J. S. B., Wong, M. K., Chua, S., Chua, D. T. C., & Howe, T. S. (2007) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.89b3.18146 · Cited by 510 · see citing works

Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking Alendronate

Lenart, B. A., Lorich, D. G., & Lane, J. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmc0707493 · Cited by 499 · see citing works

Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles

Mashiba, T., Turner, C. H., Hirano, T., Forwood, M. R., Johnston, C. C., & Burr, D. B. (2001) · Bone · doi:10.1016/s8756-3282(01)00414-8 · Cited by 483 · see citing works

Basic Epidemiology of Fractures of the Upper and Lower Limb among Americans over 65 Years of Age

Baron, J. A., Karagas, M. R., BARRETT, J. A., et al. (1996) · Epidemiology · doi:10.1097/00001648-199611000-00008 · Cited by 481 · see citing works

Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression.

Parfitt, A. M. (2002) · Bone · doi:10.1016/s8756-3282(01)00642-1 · Cited by 462 · see citing works

An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?

Kwek, E. B. K., Goh, S. K., Koh, J. S. B., Png, M. A., & Howe, T. S. (2008) · Injury · doi:10.1016/j.injury.2007.08.036 · Cited by 443 · see citing works

Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy

Weinstein, R. S., Roberson, P. K., & Manolagas, S. C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0802633 · Cited by 391 · see citing works

Fracture Incidence in Olmsted County, Minnesota: Comparison of Urban with Rural Rates and Changes in Urban Rates Over time

Melton, L. J., Crowson, C. S., & O’Fallon, W. M. (1999) · Osteoporosis International · doi:10.1007/s001980050113 · Cited by 385 · see citing works

Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women

Roschger, P., Rinnerthaler, S., Yates, J., Rodan, G. A., Fratzl, P., & Klaushofer, K. (2001) · Bone · doi:10.1016/s8756-3282(01)00485-9 · Cited by 384 · see citing works

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

Lenart, B. A., Neviaser, A. S., Lyman, S. L., Chang, C. C., Edobor‐Osula, F., Steele, B., van der Meulen, M. C. H., Lorich, D. G., & Lane, J. M. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0805-x · Cited by 383 · see citing works

Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study

Abrahamsen, B., Eiken, P., & Eastell, R. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081247 · Cited by 363 · see citing works

Seven Years of Treatment with Risedronate in Women with Postmenopausal Osteoporosis

Mellström, D., Sørensen, O. H., Goemaere, S., Roux, C., Johnson, T. D., & Chines, A. A. (2004) · Calcified Tissue International · doi:10.1007/s00223-004-0286-7 · Cited by 344 · see citing works

Fragility fractures of the hip and femur: incidence and patient characteristics

Nieves, J. W., Bilezikian, J. P., Lane, J. M., Einhorn, T. A., Wang, Y., Steinbuch, M., & Cosman, F. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0962-6 · Cited by 314 · see citing works

CT and MR Imaging Findings in Athletes with Early Tibial Stress Injuries: Comparison with Bone Scintigraphy Findings and Emphasis on Cortical Abnormalities

Gaeta, M., Minutoli, F., Scribano, E., et al. (2005) · Radiology · doi:10.1148/radiol.2352040406 · Cited by 312 · see citing works

ENHANCEMENT OF EXPERIMENTAL FRACTURE-HEALING BY SYSTEMIC ADMINISTRATION OF RECOMBINANT HUMAN PARATHYROID HORMONE (PTH 1–34)

Alkhiary, Y. M., Gerstenfeld, L. C., Krall, E. A., Westmore, M. S., Sato, M., Mitlak, B., & Einhorn, T. A. (2005) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.d.02115 · Cited by 308 · see citing works

Stress fractures: MR imaging.

Lee, J. K., & Yao, L. (1988) · Radiology · doi:10.1148/radiology.169.1.3420261 · Cited by 297 · see citing works

Incidence of fractures in a geographically defined population.

Donaldson, L., Cook, A., & Thomson, R. G. (1990) · Journal of Epidemiology & Community Health · doi:10.1136/jech.44.3.241 · Cited by 296 · see citing works

Atypical fractures of the femur and bisphosphonate therapy

Giusti, A., Hamdy, N. A. T., & Papapoulos, S. E. (2010) · Bone · doi:10.1016/j.bone.2010.05.019 · Cited by 295 · see citing works

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial

Schwartz, A. V., Bauer, D. C., Cummings, S. R., Cauley, J. A., Ensrud, K. E., Palermo, L., Wallace, R. B., Hochberg, M. C., Feldstein, A. C., Lombardi, A., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.11 · Cited by 290 · see citing works

Effects of non-enzymatic glycation on cancellous bone fragility

Tang, S. Y., Zeenath, U., & Vashishth, D. (2006) · Bone · doi:10.1016/j.bone.2006.12.056 · Cited by 285 · see citing works

Alendronate and Estrogen Effects in Postmenopausal Women with Low Bone Mineral Density

Bone, H. G. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.720 · Cited by 282 · see citing works

Constant mineralization density distribution in cancellous human bone

Roschger, P., Gupta, H. S., Berzlanovich, A. M., Ittner, G., Dempster, D. W., Fratzl, P., Cosman, F., Parisien, M. V., Lindsay, R., Nieves, J. W., et al. (2003) · Bone · doi:10.1016/s8756-3282(02)00973-0 · Cited by 273 · see citing works

Severely Suppressed Bone Turnover and Atypical Skeletal Fragility

Visekruna, M., Wilson, D., & McKiernan, F. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2803 · Cited by 267 · see citing works

Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience☆☆This study was sponsored by Procter & Gamble Pharmaceuticals, Cincinnati, Ohio, and Aventis Pharma, Bridgewater, New Jersey.

Sorensen, O. H., Crawford, G. M., Mulder, H., Hosking, D. J., Gennari, C., Mellstrom, D., Pack, S., Wenderoth, D., Cooper, C., & Reginster, J.-Y. (2003) · Bone · doi:10.1016/s8756-3282(02)00946-8 · Cited by 254 · see citing works

Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate

Allen, M. R., Iwata, K., Phipps, R. J., & Burr, D. B. (2006) · Bone · doi:10.1016/j.bone.2006.04.028 · Cited by 253 · see citing works

Bilateral Low-Energy Simultaneous or Sequential Femoral Fractures in Patients on Long-Term Alendronate Therapy

Capeci, C. M., & Tejwani, N. C. (2009) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.h.01774 · Cited by 252 · see citing works

Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats.

Cao, Y., Mori, S., Mashiba, T., Westmore, M. S., Ma, L., Sato, M., Akiyama, T., Shi, L., Komatsubara, S., Miyamoto, K., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.12.2237 · Cited by 248 · see citing works

Epidemiology of fractures in 15 000 adults

Singer, B. R., McLauchlan, G. J., Robinson, C. M., & Christie, J. H. (1998) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.80b2.0800243 · Cited by 238 · see citing works

Interpretation and classification of bone scintigraphic findings in stress fractures.

St, Z., Elkanovitch, R., & Frank, G. (1987) · PubMed · Cited by 236 · see citing works

Incidence of Fractures in Persons over 35 Years of Age: A Report to the M.R.C. Working Party on Fractures in the Elderly

Knowelden, J., Buhr, A. J., & Dunbar, O. (1964) · Journal of Epidemiology & Community Health · doi:10.1136/jech.18.3.130 · Cited by 230 · see citing works

Differential Effects of Teriparatide and Alendronate on Bone Remodeling in Postmenopausal Women Assessed by Histomorphometric Parameters

ARLOT, M. E., Meunier, P. J., Boivin, G., Haddock, L., Tamayo, J., Correa‐Rotter, R., Jasqui, S., Donley, D. W., Dalsky, G. P., Martín, J. S., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050309 · Cited by 226 · see citing works

Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links

Hernandez, C. J., Tang, S. Y., Baumbach, B. M., Hwu, P. B., Sakkee, A. N., van der Ham, F., DeGroot, J., Bank, R. A., & Keaveny, T. M. (2005) · Bone · doi:10.1016/j.bone.2005.07.019 · Cited by 226 · see citing works

Trabecular bone volume and microdamage accumulation in the femoral heads of women with and without femoral neck fractures

Mori, S., Harruff, R. C., Ambrosius, W. T., & Burr, D. B. (1997) · Bone · doi:10.1016/s8756-3282(97)00200-7 · Cited by 224 · see citing works

Effects of Intravenous Zoledronic Acid Once Yearly on Bone Remodeling and Bone Structure

Recker, R. R., Delmas, P. D., Halse, J., Reid, I. R., Boonen, S., García-Hernández, P. A., Supronik, J., Lewiecki, E. M., Ochoa, L. A., Miller, P. D., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070906 · Cited by 224 · see citing works

Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate

Tang, S. Y., Allen, M. R., Phipps, R. J., Burr, D. B., & Vashishth, D. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0754-4 · Cited by 217 · see citing works

Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae

Viguet‐Carrin, S., Roux, J. P., ARLOT, M. E., Merabet, Z., Leeming, D. J., Byrjalsen, I., Delmas, P. D., & Bouxsein, M. (2006) · Bone · doi:10.1016/j.bone.2006.05.013 · Cited by 215 · see citing works

Connexin 43 Is Required for the Anti-Apoptotic Effect of Bisphosphonates on Osteocytes and Osteoblasts In Vivo

Plotkin, L. I., Lezcano, V., Thostenson, J., Weinstein, R. S., Manolagas, S. C., & Bellido, T. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080617 · Cited by 214 · see citing works

Perspective: Quantifying Osteoblast and Osteocyte Apoptosis: Challenges and Rewards

Jilka, R. L., Weinstein, R. S., PARFITT, A. M., & Manolagas, S. C. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070518 · Cited by 211 · see citing works

The Association of Race, Gender, and Comorbidity With Mortality and Function After Hip Fracture

Penrod, J. D., Litke, A., Hawkes, W., et al. (2008) · The Journals of Gerontology Series A · doi:10.1093/gerona/63.8.867 · Cited by 211 · see citing works

Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis

Eriksen, E. F., Melsen, F., Sod, E. W., Barton, I. P., & Chines, A. A. (2002) · Bone · doi:10.1016/s8756-3282(02)00869-4 · Cited by 210 · see citing works

The Superiority of Magnetic Resonance Imaging in Differentiating the Cause of Hip Pain in Endurance Athletes

Shin, A. Y., Morin, W. D., Germany, J. D., et al. (1996) · The American Journal of Sports Medicine · doi:10.1177/036354659602400209 · Cited by 205 · see citing works

Imaging of stress fractures in the athlete

Spitz, D. J., & Newberg, A. H. (2002) · Radiologic Clinics of North America · doi:10.1016/s0033-8389(02)00010-6 · Cited by 200 · see citing works

Unusual mid‐shaft fractures during long‐term bisphosphonate therapy

Odvina, C. V., Levy, S., Rao, S., Zerwekh, J. E., & Rao, D. S. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03581.x · Cited by 186 · see citing works

Postmenopausal osteoporosis

Whyte, M., Bergfeld, M. A., Murphy, W. A., et al. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90810-5 · Cited by 182 · see citing works

Bisphosphonate Treatment Suppresses Not Only Stochastic Remodeling but Also the Targeted Repair of Microdamage

Li, J., Mashiba, T., & Burr, D. B. (2001) · Calcified Tissue International · doi:10.1007/s002230010036 · Cited by 176 · see citing works

Modulation of Dickkopf-1 Attenuates Glucocorticoid Induction of Osteoblast Apoptosis, Adipocytic Differentiation, and Bone Mass Loss

Wang, F., Ko, J., Yeh, D., Ke, H.-C., & Wu, H.-L. (2008) · Endocrinology · doi:10.1210/en.2007-0910 · Cited by 173 · see citing works

National data of 6409 Swedish inpatients with femoral shaft fractures: Stable incidence between 1998 and 2004

Weiss, R. J., Montgomery, S., Dabbagh, Z. A., et al. (2009) · Injury · doi:10.1016/j.injury.2008.07.017 · Cited by 170 · see citing works

Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis

Stepan, J. J., Burr, D. B., Pavo, I. J., Sipos, A. A., Michalská, D., Li, J., Fahrleitner‐Pammer, A., Petto, H., Westmore, M. S., Michalský, D., et al. (2007) · Bone · doi:10.1016/j.bone.2007.04.198 · Cited by 165 · see citing works

Atypical Femoral Fractures and Bisphosphonate Use

Girgis, C. M., Sher, D., & Seibel, M. J. (2010) · New England Journal of Medicine · doi:10.1056/nejmc0910389 · Cited by 161 · see citing works

Microcrack Frequency and Bone Remodeling in Postmenopausal Osteoporotic Women on Long-Term Bisphosphonates: A Bone Biopsy Study

Chapurlat, R. D., ARLOT, M. E., Burt‐Pichat, B., Chavassieux, P., Roux, J. P., Portero-Muzy, N., & Delmas, P. D. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070609 · Cited by 154 · see citing works

Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate

Schilcher, J., & Aspenberg, P. (2009) · Acta Orthopaedica · doi:10.3109/17453670903139914 · Cited by 154 · see citing works

Musculoskeletal Fatigue and Stress Fractures

(2000) · CRC Press eBooks · doi:10.1201/9781420042191 · Cited by 153 · see citing works

Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: Sequential triple biopsy studies with micro-computed tomography

Borah, B., Dufresne, T. E., Ritman, E. L., Jorgensen, S. M., Liu, S., Chmielewski, P. A., Phipps, R. J., Zhou, X., Sibonga, J. D., & Turner, R. T. (2006) · Bone · doi:10.1016/j.bone.2006.01.161 · Cited by 153 · see citing works

Population Based Epidemiologic and Morphologic Study of Femoral Shaft Fractures

Salminen, S. T., ki, H. K. P., Avikainen, V., et al. (2000) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-200003000-00026 · Cited by 152 · see citing works

Trends in Incidence of Subtrochanteric Fragility Fractures and Bisphosphonate Use Among the US Elderly, 1996–2007

Wang, Z., & Bhattacharyya, T. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.233 · Cited by 150 · see citing works

Alendronate and Estrogen Effects in Postmenopausal Women with Low Bone Mineral Density1

Bone, H. G., Greenspan, S. L., McKeever, C., Bell, N. H., Davidson, M., Downs, R. W., Emkey, R. D., Meunier, P. J., Miller, S. S., Mulloy, A. L., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6393 · Cited by 148 · see citing works

Experimental stress fractures of the tibia. Biological and mechanical aetiology in rabbits

Burr, D. B., Milgrom, C., Boyd, R. D., Higgins, W., Gc, R., & Radin, E. L. (1990) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.72b3.2341429 · Cited by 147 · see citing works

Three Years of Alendronate Treatment Results in Similar Levels of Vertebral Microdamage as After One Year of Treatment

Allen, M. R., & Burr, D. B. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070720 · Cited by 146 · see citing works

Atypical Femoral Fractures, Bisphosphonates, and Adult Hypophosphatasia

Whyte, M. P. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081253 · Cited by 145 · see citing works

Femoral Cortical Stress Lesions in Long-Term Bisphosphonate Therapy: A Herald of Impending Fracture?

Koh, J. S. B., Goh, S. K., Png, M. A., Kwek, E. B. K., & Howe, T. S. (2010) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0b013e3181b6499b · Cited by 140 · see citing works

Gender differences in epidemiology and outcome after hip fracture

Holt, G., Smith, R. S., Duncan, K., et al. (2008) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.90b4.20264 · Cited by 140 · see citing works

Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates

Lorenzini, K. I., Desmeules, J. A., Plachta, O., Suvà, D., Dayer, P., & Peter, R. E. (2009) · Drug Safety · doi:10.2165/00002018-200932090-00002 · Cited by 139 · see citing works

Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra

Allen, M. R., Gineyts, É., Leeming, D. J., Burr, D. B., & Delmas, P. D. (2007) · Osteoporosis International · doi:10.1007/s00198-007-0533-7 · Cited by 139 · see citing works

Bilateral Fractures of the Femur Diaphysis in a Patient With Rheumatoid Arthritis on Long-Term Treatment With Alendronate: Clues to the Mechanism of Increased Bone Fragility

Somford, M. P., Draijer, F. W., Thomassen, B. J. W., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090408 · Cited by 137 · see citing works

Radiographic and histologic analyses of stress fracture in rabbit tibias

Li, G., Zhang, S., Chen, G., et al. (1985) · The American Journal of Sports Medicine · doi:10.1177/036354658501300501 · Cited by 137 · see citing works

Exercise distance and speed affect the risk of fracture in racehorses

Verheyen, K. L. P., Price, J. S., Lanyon, L. E., & Wood, J. L. N. (2006) · Bone · doi:10.1016/j.bone.2006.05.025 · Cited by 134 · see citing works

Spectroscopic markers of bone quality in alendronate-treated postmenopausal women

Boskey, A. L., Spevak, L., & Weinstein, R. S. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0725-9 · Cited by 132 · see citing works

IMAGING OF STRESS INJURIES TO BONE

Deutsch, A. L., Coel, M. N., & Mink, J. H. (1997) · Clinics in Sports Medicine · doi:10.1016/s0278-5919(05)70022-3 · Cited by 126 · see citing works

Effects of 3- and 5-Year Treatment With Risedronate on Bone Mineralization Density Distribution in Triple Biopsies of the Iliac Crest in Postmenopausal Women

Zoehrer, R., Roschger, P., Paschalis, E. P., Hofstaetter, J. G., Durchschlag, E., Fratzl, P., Phipps, R. J., & Klaus Klaushofer, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060401 · Cited by 121 · see citing works

A rational approach to management of alendronate-related subtrochanteric fractures

De, S. D., Setiobudi, T., Shen, L., et al. (2010) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.92b5.22941 · Cited by 120 · see citing works

Bone Material Properties in Trabecular Bone From Human Iliac Crest Biopsies After 3- and 5-Year Treatment With Risedronate

Durchschlag, E., Paschalis, E. P., Zoehrer, R., Roschger, P., Fratzl, P., Recker, R. R., Phipps, R. J., & Klaus Klaushofer, A. (2006) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.060701 · Cited by 119 · see citing works

Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs

Saito, M., Mori, S., Mashiba, T., Komatsubara, S., & Marumo, K. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0585-3 · Cited by 119 · see citing works

Bone Turnover in Bone Biopsies of Patients with Low-Energy Cortical Fractures Receiving Bisphosphonates: A Case Series

Armamento‐Villareal, R., Napoli, N., Diemer, K., Watkins, M. P., Civitelli, R., Teitelbaum, S. L., & Novack, D. V. (2009) · Calcified Tissue International · doi:10.1007/s00223-009-9263-5 · Cited by 118 · see citing works

Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal

Bagger, Y. Z., Tankó, L. B., Alexandersen, P., Ravn, P., & Christiansen, C. (2003) · Bone · doi:10.1016/s8756-3282(03)00112-1 · Cited by 108 · see citing works

Raloxifene enhances vertebral mechanical properties independent of bone density

Allen, M. R., Iwata, K., Sato, M., & Burr, D. B. (2006) · Bone · doi:10.1016/j.bone.2006.05.007 · Cited by 108 · see citing works

Alendronate Reduces Bone Toughness of Ribs without Significantly Increasing Microdamage Accumulation in Dogs Following 3 Years of Daily Treatment

Allen, M. R., Reinwald, S., & Burr, D. B. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9131-8 · Cited by 108 · see citing works

Exercise-Induced Stress Injuries to the Femur

Clement, D. B., Ammann, W., TAUNTON, J. E., et al. (1993) · International Journal of Sports Medicine · doi:10.1055/s-2007-1021191 · Cited by 107 · see citing works

Skeletal Self-Repair : Stress Fracture Healing by Rapid Formation and Densification of Woven Bone

Uthgenannt, B. A., Kramer, M. H., Hwu, J. A., Wopenka, B., & Silva, M. J. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.0070614 · Cited by 107 · see citing works

Suppressed Bone Turnover during Alendronate Therapy for High-Turnover Osteoporosis

Armamento‐Villareal, R., Napoli, N., Panwar, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc062268 · Cited by 106 · see citing works

Stress fractures in the lower extremity

Berger, F. H., de Jonge, M. C., & Maas, M. M. (2007) · European Journal of Radiology · doi:10.1016/j.ejrad.2007.01.014 · Cited by 105 · see citing works

Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate.

Schneider, J. P. (2006) · PubMed · Cited by 105 · see citing works

Effects of Alendronate on Bone Quality and Remodeling in Glucocorticoid-Induced Osteoporosis: A Histomorphometric Analysis of Transiliac Biopsies

Chavassieux, P., ARLOT, M. E., Roux, J. P., Portero-Muzy, N., Daifotis, A. G., Yates, A. J. P., Hamdy, N. A. T., Malice, M., Freedholm, D., & Meunier, P. J. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.4.754 · Cited by 105 · see citing works

Quality of life after a subtrochanteric fracture

Ekström, W., Németh, G., Samnegård, E., Dalén, N., & Tidermark, J. (2009) · Injury · doi:10.1016/j.injury.2008.09.010 · Cited by 104 · see citing works

In vivo matrix microdamage in a naturally occurring canine fatigue fracture

Muir, P., Johnson, K. A., & Ruaux-Mason, C. P. (1999) · Bone · doi:10.1016/s8756-3282(99)00205-7 · Cited by 103 · see citing works

Successful treatment of sternal fracture nonunion with teriparatide

Chintamaneni, S., Finzel, K. C., & Gruber, B. L. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1061-4 · Cited by 102 · see citing works

Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long-term extension (FLEX)

Roschger, P., Lombardi, A., Misof, B. M., et al. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090702 · Cited by 100 · see citing works

Temporal pattern of gene expression and histology of stress fracture healing

Kidd, L. J., Stephens, A. S., Kuliwaba, J. S., Fazzalari, N. L., Wu, A., & Forwood, M. R. (2009) · Bone · doi:10.1016/j.bone.2009.10.009 · Cited by 100 · see citing works

Advanced glycation end-products and bone fractures

Vashishth, D. (2009) · IBMS BoneKEy · doi:10.1138/20090390 · Cited by 99 · see citing works

Case Reports: Two Femoral Insufficiency Fractures after Long-term Alendronate Therapy

Sayed-Noor, A. S., & Sjödén, G. (2009) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-009-0725-x · Cited by 99 · see citing works

The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits

Milgrom, C., Finestone, A. S., Novack, V., Pereg, D., Goldich, Y., Kreiss, Y., Zimlichman, E., Kaufman, S., Liebergall, M., & Burr, D. B. (2004) · Bone · doi:10.1016/j.bone.2004.04.016 · Cited by 98 · see citing works

Femoral Insufficiency Fractures Associated with Prolonged Bisphosphonate Therapy

Isaacs, J. D., Shidiak, L., Harris, I. A., et al. (2010) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-010-1535-x · Cited by 96 · see citing works

Teriparatide May Accelerate Healing in Delayed Unions of Type III Odontoid Fractures

Rubery, P. T., & Bukata, S. V. (2010) · Journal of Spinal Disorders & Techniques · doi:10.1097/bsd.0b013e31819a8b7a · Cited by 95 · see citing works

Suppressed Bone Turnover during Alendronate Therapy for High-Turnover Osteoporosis

Scott, D. L., Kingsley, M., & Ch, B. (2006) · Cited by 91 · see citing works

Dissociation of Angiogenesis and Osteoclastogenesis During Endochondral Bone Formation in Neonatal Mice

Deckers, M. M. L., van Beek, E. R., van der Pluijm, G., Wetterwald, A., van der Wee-Pals, L. J. A., Cecchini, M. G., Papapoulos, S. E., & Löwik, C. W. G. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.998 · Cited by 86 · see citing works

Evolving Data about Subtrochanteric Fractures and Bisphosphonates

Shane, E. J. (2010) · New England Journal of Medicine · doi:10.1056/nejme1003064 · Cited by 86 · see citing works

Fracture Epidemiology in a Mixed Southeastern Asian Community (Singapore)

WONG, P. C. N. (1966) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-196600450-00007 · Cited by 83 · see citing works

Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate.

Cheung, R. K. H., Leung, K. K., Lee, K. C., et al. (2007) · PubMed · Cited by 83 · see citing works

Spatial regulation and surface chemistry control of monocyte/macrophage adhesion and foreign body giant cell formation by photochemically micropatterned surfaces

DeFife, K. M., Colton, E., Nakayama, Y., Matsuda, T., & Anderson, J. M. (1999) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199905)45:2 · Cited by 76 · see citing works

Effect of Temporal Changes in Bone Turnover on the Bone Mineralization Density Distribution: A Computer Simulation Study

Ruffoni, D., Fratzl, P., Roschger, P., Phipps, R. J., Klaus Klaushofer, A., & Weinkamer, R. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080711 · Cited by 75 · see citing works

Specific Features Associated with Femoral Shaft Fractures Caused by Low-Energy Trauma

Salminen, S. T., PIHLAJAMÄKI, H. K., Avikainen, V., et al. (1997) · doi:10.1097/00005373-199707000-00027 · Cited by 73 · see citing works

Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.

Schneider, J. P. (2009) · PubMed · Cited by 71 · see citing works

Lack of Sustained Response to Teriparatide in a Patient with Adult Hypophosphatasia

Gagnon, C., Sims, N. A., Mumm, S. R., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1965 · Cited by 70 · see citing works

Stress fracture healing: Fatigue loading of the rat ulna induces upregulation in expression of osteogenic and angiogenic genes that mimic the intramembranous portion of fracture repair

Wohl, G. R., Towler, D. A., & Silva, M. J. (2008) · Bone · doi:10.1016/j.bone.2008.09.010 · Cited by 68 · see citing works

Human femoral neck has less cellular periosteum, and more mineralized periosteum, than femoral diaphyseal bone

Allen, M. R., & Burr, D. B. (2005) · Bone · doi:10.1016/j.bone.2004.10.013 · Cited by 63 · see citing works

Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene

Vestergaard, P., Schwartz, F., Rejnmark, L., & Mosekilde, L. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1512-y · Cited by 62 · see citing works

Case Reports: Subtrochanteric Femoral Stress Fractures after Prolonged Alendronate Therapy

Cermak, K., Shumelinsky, F., Alexiou, J., et al. (2009) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-009-1192-0 · Cited by 61 · see citing works

Subtrochanteric displaced insufficiency fracture after long‐term alendronate therapy—a case report

Sayed-Noor, A. S., & Sjödén, G. (2008) · Acta Orthopaedica · doi:10.1080/17453670710015580 · Cited by 60 · see citing works

Stress fractures of the femoral shaft in athletes: a new treatment algorithm

Ivković, A., Bojanić, I., & Pecina, M. M. (2006) · British Journal of Sports Medicine · doi:10.1136/bjsm.2005.023655 · Cited by 58 · see citing works

Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist up to One Year following Discontinuing Treatment

Hershman, D. L., McMahon, D. J., Crew, K. D., Shao, T. H., Cremers, S., Brafman, L., Awad, D., & Shane, E. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1366 · Cited by 57 · see citing works

Healing of non-displaced fractures produced by fatigue loading of the mouse ulna

Martinez, M. D., Schmid, G. J., McKenzie, J. A., et al. (2010) · Bone · doi:10.1016/j.bone.2010.02.030 · Cited by 57 · see citing works

Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: Implications for subtrochanteric femoral fracture risk

Burr, D. B., Diab, T., Koivunemi, A., Koivunemi, M., & Allen, M. R. (2009) · Journal of Orthopaedic Research® · doi:10.1002/jor.20895 · Cited by 56 · see citing works

Imaging bone microdamage in vivo with positron emission tomography

Li, J., Miller, M. A., Hutchins, G. D., & Burr, D. B. (2005) · Bone · doi:10.1016/j.bone.2005.06.022 · Cited by 56 · see citing works

Atraumatic Bilateral Femur Fracture in Long-Term Bisphosphonate Use

Goddard, M. S., Reid, K. R., Johnston, J. C., et al. (2009) · Orthopedics · doi:10.3928/01477447-20090624-27 · Cited by 56 · see citing works

Looking beyond low bone mineral density: Multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy

Lee, P., der Wall, H. V., & Seibel, M. J. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03346353 · Cited by 55 · see citing works

Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach

Hauge, E., Mosekilde, L., & Melsen, F. (1999) · Bone · doi:10.1016/s8756-3282(99)00194-5 · Cited by 53 · see citing works

Risedronate treatment does not increase microdamage in the canine femoral neck

Forwood, M. R., Burr, D. B., Takano, Y., Eastman, D., Smith, P. N., & Schwardt, J. D. (1995) · Bone · doi:10.1016/8756-3282(95)00120-3 · Cited by 50 · see citing works

Low‐intensity pulsed ultrasound and nonsteroidal anti‐inflammatory drugs have opposing effects during stress fracture repair

Li, J., Waugh, L. J., Hui, S. L., Burr, D. B., & Warden, S. J. (2007) · Journal of Orthopaedic Research® · doi:10.1002/jor.20461 · Cited by 49 · see citing works

Alendronate-related femoral diaphysis fracture—what should be done to predict and prevent subsequent fracture of the contralateral side?

Edwards, M. H., McCrae, F., & Young‐Min, S. A. (2009) · Osteoporosis International · doi:10.1007/s00198-009-0986-y · Cited by 48 · see citing works

Magnetic resonance imaging appearances of fatigue fractures of the long bones of the lower limb

Tyrrell, P. N. M., & Davies, A. M. (1994) · British Journal of Radiology · doi:10.1259/0007-1285-67-796-332 · Cited by 44 · see citing works

Discontinuing Antiresorptive Therapy One Year after Cardiac Transplantation: Effect on Bone Density and Bone Turnover

Cohen, A., Addesso, V., McMahon, D. J., et al. (2006) · Transplantation · doi:10.1097/01.tp.0000177645.63999.ca · Cited by 43 · see citing works

Case Report of Spontaneous, Nonspinal Fractures in a Multiple Myeloma Patient on Long-term Pamidronate and Zoledronic Acid

Wernecke, G., Namduri, S., DiCarlo, E. F., et al. (2008) · HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery · doi:10.1007/s11420-008-9077-4 · Cited by 43 · see citing works

Subtrochanteric stress fracture of the femur following total knee arthroplasty

Kumm, D. A., Rack, C., & Rütt, J. (1997) · The Journal of Arthroplasty · doi:10.1016/s0883-5403(97)90184-4 · Cited by 42 · see citing works

Incidence of hip fracture in Shiraz, Iran

Soveid, M., Serati, A. R., & Masoompoor, M. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1854-z · Cited by 41 · see citing works

Computed Tomography of Stress Fractures

Yousem, D. M., Magid, D., Fishman, E. K., et al. (1986) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198601000-00020 · Cited by 34 · see citing works

Spontaneous femoral shaft fracture after long-term alendronate

Ali, T., & Jay, R. H. (2009) · Age and Ageing · doi:10.1093/ageing/afp106 · Cited by 34 · see citing works

Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium

Lee, J. K. (2009) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2009.01396.x · Cited by 31 · see citing works

Correction to the article “age-related changes in the collagen network and toughness of bone” [bone 31:1–7, 2002]

Wang, X., Shen, X., Li, X., & Agrawal, C. M. (2003) · Bone · doi:10.1016/s8756-3282(03)00016-4 · Cited by 30 · see citing works

Effect of short‐term treatment with alendronate on ulnar bone adaptation to cyclic fatigue loading in rats

Barrett, J. G., Sample, S. J., McCarthy, J., Kalscheur, V. L., Muir, P., & Prokuski, L. J. (2007) · Journal of Orthopaedic Research® · doi:10.1002/jor.20395 · Cited by 29 · see citing works

LOW-ENERGY SUBTROCHANTERIC FRACTURES IN ELDERLY PATIENTS

Mullaji, A., Orth, D., Orth, M. S., et al. (1993) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199301000-00010 · Cited by 28 · see citing works

Bilateral femoral insuffiency fractures treated with inflatable intramedullary nails: a case report

Demiralp, B., Ilgan, S., Karaçalıoğlu, A. Ö., et al. (2007) · Archives of Orthopaedic and Trauma Surgery · doi:10.1007/s00402-007-0373-0 · Cited by 26 · see citing works

Prevention of corticosteroid-induced osteonecrosis in rabbits by intra-bone marrow injection of autologous bone marrow cells

Asada, T., Kushida, T., Umeda, M., Oe, K., Matsuya, H., Wada, T., Sasai, K., Ikehara, S., & Iida, H. (2008) · Lara D. Veeken · doi:10.1093/rheumatology/ken037 · Cited by 26 · see citing works

Recurrent Low-Energy Femoral Shaft Fractures and Osteonecrosis of the Jaw in a Case of Multiple Myeloma Treated With Bisphosphonates

Grasko, J. M., Herrmann, R., & Vasikaran, S. D. (2009) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2008.11.005 · Cited by 25 · see citing works

Atypical femoral diaphyseal and subtrochanteric fractures and their association with bisphosphonates

Leung, F. K. L., Lau, T.-W., To, M. K.-T., et al. (2009) · BMJ Case Reports · doi:10.1136/bcr.10.2008.1073 · Cited by 24 · see citing works

Subtrochanteric Femoral Insufficiency Fracture Following Bisphosphonate Therapy for Osseous Metastases

Bush, L. A., & Chew, F. S. (2008) · Radiology Case Reports · doi:10.2484/rcr.v3i4.232 · Cited by 24 · see citing works

Bisphosphonate-associated femoral fracture: implications for management in patients with malignancies

Napoli, N., Novack, D. V., & Armamento‐Villareal, R. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1012-0 · Cited by 23 · see citing works

Bisphosphonate treatment and fracture repair

McDonald, M. M., Schindeler, A., & Little, D. G. (2007) · BoneKEy-Osteovision · doi:10.1138/20070271 · Cited by 18 · see citing works

Long-Term Alendronate Use Not without Consequences?

Somford, M. P., Geurts, G. F. A. E., den Teuling, J. W. A. M., et al. (2009) · International Journal of Rheumatology · doi:10.1155/2009/253432 · Cited by 18 · see citing works

Low‐Energy Femoral Fractures Associated With Long‐Term Bisphosphonate Use in a Rehabilitation Setting: A Case Series

Bunning, R. D., Rentfro, R. J., & Jelinek, J. S. (2010) · PM&R · doi:10.1016/j.pmrj.2009.11.007 · Cited by 18 · see citing works

Bilateral Mid-Diaphyseal Femoral Stress Fractures in the Elderly

Husada, G., Libberecht, K., Peeters, T., et al. (2005) · European Journal of Trauma · doi:10.1007/s00068-005-1421-5 · Cited by 17 · see citing works

Microcrack initiation occurs more easily in vertebrae from beagles treated with alendronate than with risedronate

Iwata, K., Allen, M. R., Phipps, R. L., & Burr, D. B. (2006) · Bone · doi:10.1016/j.bone.2005.12.023 · Cited by 17 · see citing works

Subtrochanteric stress fractures in six patients on long term bisphosphonate therapy: A case series

Glennon, D. A. (2009) · Bone · doi:10.1016/j.bone.2009.01.172 · Cited by 12 · see citing works

The Role of Various Imaging Modalities in Diagnosing Stress Fractures

Chisin, R. (2000) · CRC Press eBooks · doi:10.1201/9781420042191-23 · Cited by 8 · see citing works

Bucked Shins in Horses

Nunamaker, D. (2000) · CRC Press eBooks · doi:10.1201/9781420042191-17 · Cited by 7 · see citing works

Atraumatic Bilateral Femur Fracture in Long-Term Bisphosphonate Use

Yli-Kyyny, T. T., Tamminen, I. S., & Kröger, H. (2010) · Orthopedics · doi:10.3928/01477447-20101021-37 · Cited by 7 · see citing works

Principles of Bone Biomechanics

Turner, C. H., & Burr, D. B. (2006) · Elsevier eBooks · doi:10.1016/b978-0-323-03437-1.50013-0 · Cited by 6 · see citing works

Subtrochanteric and diaphyseal fractures in patients during long-term alendronate treatment: Expanded and extended national register based cohort study

Abrahamsen, B., Eiken, P., & Eastell, R. (2010) · Bone · doi:10.1016/j.bone.2010.04.120 · Cited by 3 · see citing works

Case Series: Atypical Subtrochanteric Femoral Fractures After Potent Anti-Resorptive Therapy

Wimalawansa, S. J., Sagebien, C. A., Masella, R. M., et al. (2011) · Journal of Clinical Densitometry · doi:10.1016/j.jocd.2011.02.037 · Cited by 1 · see citing works

An overview and management of osteoporosis

Sözen, T., Özışık, L., & Çalık Başaran, N. (2019) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2016.048 · Cited by 2,262 · see citing works

Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American Society for Bone and Mineral Research

Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1998 · Cited by 2,147 · see citing works

American Association of Clinical Endocrinologists/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update

Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., et al. (2020) · Endocrine Practice · doi:10.4158/gl-2020-0524suppl · Cited by 1,182 · see citing works

American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary

Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140 · see citing works

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Bone, H. G., Wagman, R. B., Brandi, M. L., Brown, J. P., Chapurlat, R., Cummings, S. R., Czerwiński, E., Fahrleitner-Pammer, A., Kendler, D. L., Lippuner, K., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30138-9 · Cited by 996 · see citing works

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline

Eastell, R., Rosen, C. J., Black, D. M., Cheung, A. M., Murad, M. H., & Shoback, D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00221 · Cited by 868 · see citing works

The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

Black, D. M., Reid, I. R., Boonen, S., Bucci-Rechtweg, C., Cauley, J. A., Cosman, F., Cummings, S. R., Hue, T. F., Lippuner, K., Lakatos, P., et al. (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1494 · Cited by 700 · see citing works

Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline

Watts, N. B., Adler, R. A., Bilezikian, J. P., Drake, M. T., Eastell, R., Orwoll, E. S., & Finkelstein, J. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-3045 · Cited by 611 · see citing works

UK clinical guideline for the prevention and treatment of osteoporosis

Gregson, C. L., Armstrong, D. J., Bowden, J., Cooper, C., Edwards, J., Gittoes, N. J. L., Harvey, N., Kanis, J., Leyland, S., Low, R., et al. (2022) · Archives of Osteoporosis · doi:10.1007/s11657-022-01061-5 · Cited by 593 · see citing works

Use of bone turnover markers in postmenopausal osteoporosis

Eastell, R., & Szulc, P. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30184-5 · Cited by 594 · see citing works

Benefits and risks of bisphosphonate therapy for osteoporosis

Khosla, S., Bilezikian, J. P., Dempster, D. W., Lewiecki, E. M., Miller, P. D., Neer, R. M., Recker, R. R., Shane, E., Shoback, D., & Potts, J. T. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1027 · Cited by 290 · see citing works

Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development

Li, H., Xiao, Z., Quarles, L. D., & Li, W. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867327666200330142432 · Cited by 226 · see citing works

Crucial Role of Vitamin D in the Musculoskeletal System

Wintermeyer, E., Ihle, C., Ehnert, S., Stöckle, U., Ochs, G., De Zwart, P., Flesch, I., Bahrs, C., & Nussler, A. (2016) · Nutrients · doi:10.3390/nu8060319 · Cited by 216 · see citing works

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

McClung, M. R., O'Donoghue, M. L., Papapoulos, S. E., Bone, H., Langdahl, B., Saag, K. G., Reid, I. R., Kiel, D. P., Cavallari, I., Bonaca, M. P., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30346-8 · Cited by 169 · see citing works

The fracture mechanics of human bone: influence of disease and treatment

Zimmermann, E. A., Busse, B., & Ritchie, R. O. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.112 · Cited by 164 · see citing works

Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance

Lloyd, A. A., Gludovatz, B., Riedel, C., Luengo, E. A., Saiyed, R., Marty, E., Lorich, D. G., Lane, J. M., Ritchie, R. O., Busse, B., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704460114 · Cited by 158 · see citing works

A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: The oral calcitonin in postmenopausal osteoporosis (ORACAL) trial

Binkley, N., Bolognese, M., Sidorowicz-Bialynicka, A., Vally, T., Trout, R., Miller, C., Buben, C. E., Gilligan, J. P., Krause, D. S., & for the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1602 · Cited by 149 · see citing works

Bisphosphonate-osteoclasts: Changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients

Jobke, B., Milovanovic, P., Amling, M., & Busse, B. (2014) · Bone · doi:10.1016/j.bone.2013.10.024 · Cited by 123 · see citing works

Medical Treatment for Osteoporosis: From Molecular to Clinical Opinions

Chen, L.-R., Ko, N.-Y., & Chen, K.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092213 · Cited by 116 · see citing works

Romosozumab for the treatment of osteoporosis

Bandeira, L., Lewiecki, E. M., & Bilezikian, J. P. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1280455 · Cited by 101 · see citing works

Uncertainties in the prevention and treatment of glucocorticoid-induced osteoporosis

Hansen, K. E., Wilson, H. A., Zapalowski, C., Fink, H. A., Minisola, S., & Adler, R. A. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.362 · Cited by 65 · see citing works

Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene

Vestergaard, P., Schwartz, F., Rejnmark, L., & Mosekilde, L. (2011) · Osteoporosis International · doi:10.1007/s00198-010-1512-y · Cited by 62 · see citing works

Fusion of electronic health records and radiographic images for a multimodal deep learning prediction model of atypical femur fractures

Schilcher, J., Nilsson, A., Andlid, O., & Eklund, A. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107704 · Cited by 41 · see citing works

The effect of osteoporosis treatments on fatigue properties of cortical bone tissue

Brock, G. R., Chen, J. T., Ingraffea, A. R., MacLeay, J., Pluhar, G. E., Boskey, A. L., & van der Meulen, M. C. H. (2015) · Bone Reports · doi:10.1016/j.bonr.2014.10.004 · Cited by 33 · see citing works

Prevention of glucocorticoid induced bone changes with beta-ecdysone

Dai, W., Jiang, L., Lay, Y.-A. E., Chen, H., Jin, G., Zhang, H., Kot, A., Ritchie, R. O., Lane, N. E., & Yao, W. (2015) · Bone · doi:10.1016/j.bone.2015.01.001 · Cited by 30 · see citing works

The effectiveness of human parathyroid hormone and low-intensity pulsed ultrasound on the fracture healing in osteoporotic bones

Mansjur, K. Q., Kuroda, S., Izawa, T., Maeda, Y., Sato, M., Watanabe, K., Horiuchi, S., & Tanaka, E. (2016) · Annals of Biomedical Engineering · doi:10.1007/s10439-015-1533-y · Cited by 27 · see citing works

The effects of organic nitrates on osteoporosis: A systematic review

Jamal, S. A., Reid, L. S., & Hamilton, C. J. (2013) · Osteoporosis International · doi:10.1007/s00198-012-2262-9 · Cited by 27 · see citing works

Bone safety of low-dose glucocorticoids in rheumatic diseases

Saag, K. G. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12446 · Cited by 15 · see citing works

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

Genentech taps Affimed’s antibodies

Cross, R. (2018) · C&EN Global Enterprise · doi:10.1021/cen-09635-buscon15

KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK

Sari, D. (2023) · Jurnal Komplikasi Anestesi · doi:10.22146/jka.v5i1.7322

Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria

Dib, A., Puig, L. B., Salvadori, D., et al. (1988) · Arquivos Brasileiros de Cardiologia

Interleucinas na encefalopatia hipóxico-isquêmica

Ceccon, M. E. J. R. (2003) · Jornal de Pediatria · doi:10.1590/s0021-75572003000400002 · Cited by 14 · see citing works